Immunogenicity and Safety Study of Serum-Free Avonex

Clinical trial NCT00912860 · COMPLETED

Trial details

NCT number: NCT00912860
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2003-01-01
Primary completion: 2004-12-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.